Search by Drug Name or NDC
NDC 70121-1580-05 prochlorperazine edisylate 5 mg/mL Details
prochlorperazine edisylate 5 mg/mL
prochlorperazine edisylate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is PROCHLORPERAZINE EDISYLATE.
Product Information
| NDC | 70121-1580 |
|---|---|
| Product ID | 70121-1580_7b04e23e-b98c-46e5-b39b-c3aa10e5b753 |
| Associated GPIs | |
| GCN Sequence Number | 067700 |
| GCN Sequence Number Description | prochlorperazine edisylate VIAL 10 MG/2 ML INJECTION |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 30314 |
| HICL Sequence Number | 001628 |
| HICL Sequence Number Description | PROCHLORPERAZINE EDISYLATE |
| Brand/Generic | Generic |
| Proprietary Name | prochlorperazine edisylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | prochlorperazine edisylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | PROCHLORPERAZINE EDISYLATE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214192 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70121-1580-05 (70121158005)
| NDC Package Code | 70121-1580-5 |
|---|---|
| Billing NDC | 70121158005 |
| Package | 25 VIAL in 1 CARTON (70121-1580-5) / 2 mL in 1 VIAL (70121-1580-1) |
| Marketing Start Date | 2022-12-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |